Login to Your Account

BioAsia 2018

Biosimilars on the rise in India; technology, capital remain challenges

By T.V. Padma
Staff Writer

Wednesday, March 7, 2018

HYDERABAD, India – Companies are increasingly willing to invest in biosimilar development and manufacturing in India, despite a spate of regulatory hurdles and a shortage of capital that remain visible.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription